Get started
REMEDY ENTMT OYJREMEDY ENTMT OYJREMEDY ENTMT OYJ

REMEDY ENTMT OYJ

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪247.40 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.12 USD
Net income (FY)
‪−15.30 M‬ USD
Revenue (FY)
‪69.90 M‬ USD
Shares float
‪9.06 M‬
Beta (1Y)
0.88

Employees


Employees (FY)
387
Change (1Y)
+20 +5.45%
Revenue / Employee (1Y)
‪180.61 K‬ USD
Net income / Employee (1Y)
‪−39.54 K‬ USD

About Remedy Entertainment Oy


Sector
Technology Services
Industry
Packaged Software
CEO
Markus Heimo Tapio Mäki
Website
remedygames.com
Headquarters
Espoo
Founded
1995
IPO date
May 29, 2017
Identifiers
2
ISIN FI4000251897
Remedy Entertainment Plc engages in the production and development of story-driven console and computer games. The firm's product franchises include Control, Alan Wake, and Max Payne. The company was founded by Markus Heimo Tapio Maki in August 1995 and is headquartered in Espoo, Finland.

Check out other big names from the same industry as RMDEF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RMDEF is 16.76 USD — it has decreased by −6.47% in the past 24 hours. Watch REMEDY ENTMT OYJ stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange REMEDY ENTMT OYJ stocks are traded under the ticker RMDEF.
RMDEF stock has fallen by −6.47% compared to the previous week, the month change is a −6.47% fall, over the last year REMEDY ENTMT OYJ has showed a 22.20% increase.
We've gathered analysts' opinions on REMEDY ENTMT OYJ future price: according to them, RMDEF price has a max estimate of 22.16 USD and a min estimate of 18.66 USD. Watch RMDEF chart and read a more detailed REMEDY ENTMT OYJ stock forecast: see what analysts think of REMEDY ENTMT OYJ and suggest that you do with its stocks.
RMDEF reached its all-time high on Sep 28, 2023 with the price of 26.05 USD, and its all-time low was 13.72 USD and was reached on Nov 20, 2024. View more price dynamics on RMDEF chart.
See other stocks reaching their highest and lowest prices.
RMDEF stock is 6.92% volatile and has beta coefficient of 0.88. Track REMEDY ENTMT OYJ stock price on the chart and check out the list of the most volatile stocks — is REMEDY ENTMT OYJ there?
Today REMEDY ENTMT OYJ has the market capitalization of ‪246.49 M‬, it has decreased by −3.63% over the last week.
Yes, you can track REMEDY ENTMT OYJ financials in yearly and quarterly reports right on TradingView.
REMEDY ENTMT OYJ is going to release the next earnings report on May 5, 2026. Keep track of upcoming events with our Earnings Calendar.
RMDEF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.16 USD resulting in a −78.64% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about REMEDY ENTMT OYJ earnings.
REMEDY ENTMT OYJ revenue for the last quarter amounts to ‪19.99 M‬ USD, despite the estimated figure of ‪21.16 M‬ USD. In the next quarter, revenue is expected to reach ‪13.46 M‬ USD.
RMDEF net income for the last quarter is ‪470.98 K‬ USD, while the quarter before that showed ‪−15.79 M‬ USD of net income which accounts for 102.98% change. Track more REMEDY ENTMT OYJ financial stats to get the full picture.
As of Feb 14, 2026, the company has 387 employees. See our rating of the largest employees — is REMEDY ENTMT OYJ on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REMEDY ENTMT OYJ EBITDA is ‪13.32 M‬ USD, and current EBITDA margin is 19.06%. See more stats in REMEDY ENTMT OYJ financial statements.
Like other stocks, RMDEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REMEDY ENTMT OYJ stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REMEDY ENTMT OYJ technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REMEDY ENTMT OYJ stock shows the strong sell signal. See more of REMEDY ENTMT OYJ technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.